Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Silent Tech Titans-in-the-Making: Invest Before They Skyrocket

By Yiannis Zourmpanos, InvestorPlace Contributor
Unlock the potential of tech sector investments with insights on three stocks poised for remarkable growth in diverse industries.

3 Penny Stocks That Pay Investors 8% to Own Them

By Alex Sirois, InvestorPlace Contributor
8% dividend-paying penny stocks like these offer substantial pricing upside combined with strong income for investors.

The Millionaire’s Watchlist: 3 Stocks Set for a Meteoric Rise

By Yiannis Zourmpanos, InvestorPlace Contributor
From biotechnology to digital tech endeavors, these stocks offer huge promise for the future, making them stocks to buy now.

Stock Splits Watch: 3 Likely Candidates to Keep on Your Radar in 2024

By Joel Baglole, InvestorPlace Contributor
Investors should keep a close eye on these companies as rumors grow louder that stock splits are imminent.

Why Is Vivani Medical (VANI) Stock Up 300% Today?

By Josh Enomoto, InvestorPlace Contributor
With Vivani Medical introducing pre-clinical efficacy data for its weight-loss solution, VANI stock soared on the broader implications.

NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today

By William White, InvestorPlace Writer
Novavax stock is falling hard on Wednesday as NVAX investors react to it missing estimates for Q4 and posting weak guidance for 2024!

7 Dividend Stocks to Buy to Secure Steady Income

By Yiannis Zourmpanos, InvestorPlace Contributor
Unlock financial growth with 7 standout dividend stocks in real estate, industrial, pharma, and telecom sectors for long-term success.

Why Is Applied Therapeutics (APLT) Stock Up 59% Today?

By William White, InvestorPlace Writer
Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.

Why Is Oragenics (OGEN) Stock Down 45% Today?

By William White, InvestorPlace Writer
Oragenics stock is falling on Wednesday as investors in OGEN react to the pricing of a public offering for the company's shares.

Tech Trailblazers: 7 Small-Cap Stocks on the Verge of a Breakthrough

By Jeremy Flint, InvestorPlace Contributor
These small-cap tech stocks are well on their way to a meteoric and historic rise, but it isn't too late to jump on the bandwagon.

3 Cannabis Stocks Blazing a Trail to Legalization

By Muslim Farooque, InvestorPlace Contributor
Capitalizing on the regulatory momentum, wager on these top cannabis stocks primed for robust expansion in the evolving market.

3 Long-Term Winners from Charles Schwab’s Top Picks

By Stavros Tousios, InvestorPlace Contributor
Explore the growth and resilience of long-term stocks Microsoft, Merck and Veralto in the latest Charles Schwab stocks portfolio update.

Why Is Viking Therapeutics (VKTX) Stock Up 96% Today?

By William White, InvestorPlace Writer
Viking Therapeutics stock is up on Tuesday with heavy trading of VKTX shares after the company reported positive Phase 2 trial results!

Why Is NRX Pharmaceuticals (NRXP) Stock Down 23% Today?

By William White, InvestorPlace Writer
NRX Pharmaceuticals stock is falling on Tuesday after the company announced plans for a proposed public offering of NRXP shares.

Why Is Janux Therapeutics (JANX) Stock Up 108% Today?

By William White, InvestorPlace Writer
Janux Therapeutics stock is rocketing higher on Tuesday after the company provided JANX shareholders with clinical trial updates.

3 Vice Stocks That Can Make a Gloomy February Sizzle

By Josh Enomoto, InvestorPlace Contributor
We’re all thinking about it but we don’t say it out loud – that’s the underlying theme behind vice stocks. During an economically challenging cycle,…

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

By Josh Enomoto, InvestorPlace Contributor
While biotech stocks offer some of the most pertinent ideas available in the market, they can be awfully risky. One bad clinical result and boom…

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024

By Tezcan Gecgil, InvestorPlace Contributor
Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.

3 Blue-Chip Stocks to Buy to Bolster Your Portfolio

By Yiannis Zourmpanos, InvestorPlace Contributor
Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare.
Load More Articles